CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
|
Series A Convertible Preferred Stock |
Series B Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Stock Receivable |
Accumulated Deficit |
Non-controlling Interest |
Total |
Beginning balance - shares at Mar. 31, 2019 |
5,000,000
|
0
|
301,758,293
|
|
|
|
|
|
Beginning balance - amount at Mar. 31, 2019 |
$ 500
|
$ 0
|
$ 30,177
|
$ 38,335,782
|
$ 0
|
$ (41,223,445)
|
$ 0
|
$ (2,856,986)
|
Issuance of shares under equity financing agreement - shares |
|
|
11,482,721
|
|
|
|
|
|
Issuance of shares under equity financing agreement - amount |
|
|
$ 1,148
|
1,498,852
|
|
|
|
1,500,000
|
Issuance of common stock upon conversion - shares |
|
|
3,000,000
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 300
|
29,700
|
|
|
|
30,000
|
Beneficial conversion feature related to the Series B Preferred Shares |
|
|
|
58,548
|
|
|
|
58,548
|
Net loss |
|
|
|
|
|
(795,270)
|
|
(795,270)
|
Ending balance - shares at Jun. 30, 2019 |
5,000,000
|
0
|
316,241,014
|
|
|
|
|
|
Ending balance - amount at Jun. 30, 2019 |
$ 500
|
$ 0
|
$ 31,625
|
39,922,882
|
0
|
(42,018,715)
|
0
|
(2,063,708)
|
Beginning balance - shares at Mar. 31, 2019 |
5,000,000
|
0
|
301,758,293
|
|
|
|
|
|
Beginning balance - amount at Mar. 31, 2019 |
$ 500
|
$ 0
|
$ 30,177
|
38,335,782
|
0
|
(41,223,445)
|
0
|
(2,856,986)
|
Issuance of common stock upon conversion - amount |
|
|
|
|
|
|
|
383,448
|
Series B PS Dividends in kind issued - amount |
|
|
|
|
|
|
|
0
|
Net loss |
|
|
|
|
|
|
|
(2,192,827)
|
Ending balance - shares at Dec. 31, 2019 |
5,000,000
|
1,500,000
|
354,116,535
|
|
|
|
|
|
Ending balance - amount at Dec. 31, 2019 |
$ 500
|
$ 0
|
$ 35,411
|
42,434,545
|
0
|
(43,744,909)
|
(51,363)
|
(1,325,816)
|
Beginning balance - shares at Jun. 30, 2019 |
5,000,000
|
0
|
316,241,014
|
|
|
|
|
|
Beginning balance - amount at Jun. 30, 2019 |
$ 500
|
$ 0
|
$ 31,625
|
39,922,882
|
0
|
(42,018,715)
|
0
|
(2,063,708)
|
Issuance of shares under equity financing agreement - shares |
|
|
3,275,060
|
|
|
|
|
|
Issuance of shares under equity financing agreement - amount |
|
|
$ 326
|
273,675
|
|
|
|
274,001
|
Issuance of common stock upon conversion - shares |
|
|
14,000,000
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 1,400
|
138,600
|
|
|
|
140,000
|
Purchase of Series B Preferred shares - shares |
|
250
|
|
|
|
|
|
|
Purchase of Series B Preferred shares - amount |
|
$ 0
|
|
250,000
|
|
|
|
250,000
|
Net loss |
|
|
|
|
|
(856,711)
|
|
(856,711)
|
Ending balance - shares at Sep. 30, 2019 |
5,000,000
|
250
|
333,516,074
|
|
|
|
|
|
Ending balance - amount at Sep. 30, 2019 |
$ 500
|
$ 0
|
$ 33,351
|
40,585,157
|
0
|
(42,875,426)
|
0
|
(2,256,418)
|
Issuance of common stock upon conversion - shares |
|
|
20,600,461
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 2,060
|
211,388
|
|
|
|
213,448
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures |
|
|
|
8,000
|
|
|
|
8,000
|
Purchase of Series B Preferred shares - shares |
|
1,250
|
|
|
|
|
|
|
Purchase of Series B Preferred shares - amount |
|
$ 0
|
|
1,250,000
|
|
|
|
1,250,000
|
Beneficial conversion feature related to the Series B Preferred Shares |
|
|
|
380,000
|
|
(380,000)
|
|
0
|
Net loss |
|
|
|
|
|
(489,483)
|
(51,363)
|
(540,846)
|
Ending balance - shares at Dec. 31, 2019 |
5,000,000
|
1,500,000
|
354,116,535
|
|
|
|
|
|
Ending balance - amount at Dec. 31, 2019 |
$ 500
|
$ 0
|
$ 35,411
|
42,434,545
|
0
|
(43,744,909)
|
(51,363)
|
(1,325,816)
|
Beginning balance - shares at Mar. 31, 2020 |
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
|
Beginning balance - amount at Mar. 31, 2020 |
$ 500
|
$ 0
|
$ 37,975
|
43,533,242
|
0
|
(46,427,396)
|
(82,101)
|
(2,937,780)
|
Issuance of common stock upon conversion - shares |
|
|
37,926,239
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 3,793
|
222,644
|
|
|
|
226,437
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures |
|
|
|
205,000
|
|
|
|
205,000
|
Purchase of Series B Preferred shares - shares |
|
1,250
|
|
|
|
|
|
|
Purchase of Series B Preferred shares - amount |
|
$ 0
|
|
1,250,000
|
|
|
|
1,250,000
|
Beneficial conversion feature related to the Series B Preferred Shares |
|
|
|
293,000
|
|
(293,000)
|
|
0
|
Dividends payable on Series B PS |
|
|
|
(144,792)
|
|
|
|
(144,792)
|
Series B PS Dividends in kind issued - shares |
|
50
|
|
|
|
|
|
|
Series B PS Dividends in kind issued - amount |
|
$ 0
|
|
56,458
|
|
|
|
56,458
|
Conversion of Series B PS to common stock - shares |
|
(800)
|
33,569,730
|
|
|
|
|
|
Conversion of Series B PS to common stock - amount |
|
$ 0
|
$ 3,357
|
(3,357)
|
|
|
|
0
|
Common stock issued in Vista Warrant settlement - shares |
|
|
17,500,000
|
|
|
|
|
|
Common stock issued in Vista Warrant settlement - amout |
|
|
$ 1,750
|
608,250
|
|
|
|
610,000
|
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement |
|
|
|
90,000
|
|
|
|
90,000
|
Common stock issued to consultant - shares |
|
|
1,250,000
|
|
|
|
|
|
Common stock issued to consultant - amount |
|
|
$ 125
|
61,125
|
|
|
|
61,250
|
Net loss |
|
|
|
|
|
(477,072)
|
(1,895)
|
(478,967)
|
Ending balance - shares at Jun. 30, 2020 |
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
|
Ending balance - amount at Jun. 30, 2020 |
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
(1,062,394)
|
Beginning balance - shares at Mar. 31, 2020 |
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
|
Beginning balance - amount at Mar. 31, 2020 |
$ 500
|
$ 0
|
$ 37,975
|
43,533,242
|
0
|
(46,427,396)
|
(82,101)
|
(2,937,780)
|
Issuance of common stock upon conversion - amount |
|
|
|
|
|
|
|
1,131,824
|
Series B PS Dividends in kind issued - amount |
|
|
|
|
|
|
|
134,446
|
Net loss |
|
|
|
|
|
|
|
(1,678,684)
|
Ending balance - shares at Dec. 31, 2020 |
5,000,000
|
1,920
|
544,989,181
|
|
|
|
|
|
Ending balance - amount at Dec. 31, 2020 |
$ 500
|
$ 0
|
$ 54,500
|
55,437,431
|
135,775
|
(49,961,843)
|
(86,756)
|
5,578,832
|
Beginning balance - shares at Jun. 30, 2020 |
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
|
Beginning balance - amount at Jun. 30, 2020 |
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
(1,062,394)
|
Issuance of common stock upon conversion - shares |
|
|
1,014,001
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 101
|
125,365
|
|
|
|
125,736
|
Purchase of Series B Preferred shares - shares |
|
1,250
|
|
|
|
|
|
|
Purchase of Series B Preferred shares - amount |
|
$ 0
|
|
1,250,000
|
|
|
|
1,250,000
|
Beneficial conversion feature related to the Series B Preferred Shares |
|
$ 65
|
|
807,000
|
|
(807,000)
|
|
0
|
Dividends payable on Series B PS |
|
|
|
|
|
(83,960)
|
|
(83,960)
|
Series B PS Dividends in kind issued - amount |
|
|
|
77,984
|
|
|
|
77,984
|
Conversion of Series B PS to common stock - shares |
|
(2,369)
|
58,521,249
|
|
|
|
|
|
Conversion of Series B PS to common stock - amount |
|
$ 0
|
$ 5,852
|
(5,852)
|
|
|
|
0
|
Common stock issued to consultant - shares |
|
|
1,500,000
|
|
|
|
|
|
Common stock issued to consultant - amount |
|
|
$ 150
|
67,350
|
|
|
|
67,500
|
Net loss |
|
|
|
|
|
(588,193)
|
(1,686)
|
(589,879)
|
Ending balance - shares at Sep. 30, 2020 |
5,000,000
|
1,696
|
531,023,743
|
|
|
|
|
|
Ending balance - amount at Sep. 30, 2020 |
$ 500
|
$ 0
|
$ 53,103
|
48,638,480
|
0
|
(48,821,413)
|
(85,682)
|
(215,012)
|
Issuance of common stock upon conversion - shares |
|
|
795,387
|
|
|
|
|
|
Issuance of common stock upon conversion - amount |
|
|
$ 80
|
198,768
|
|
|
|
198,848
|
Purchase of Series B Preferred shares - shares |
|
750
|
|
|
|
|
|
|
Purchase of Series B Preferred shares - amount |
|
$ 0
|
|
750,000
|
|
|
|
750,000
|
Beneficial conversion feature related to the Series B Preferred Shares |
|
|
|
235,000
|
|
(235,000)
|
|
0
|
Dividends payable on Series B PS |
|
|
|
|
|
(88,333)
|
|
(88,333)
|
Conversion of Series B PS to common stock - shares |
|
(256)
|
5,670,051
|
|
|
|
|
|
Conversion of Series B PS to common stock - amount |
|
$ 0
|
$ 567
|
(567)
|
|
|
|
0
|
Beneficial conversion feature related to the Series D Preferred shares |
|
|
|
5,000,000
|
|
|
|
5,000,000
|
Amortization of beneficial conversion feature related to the Series D Preferred Shares |
|
|
|
|
|
(208,333)
|
|
(208,333)
|
Commitment shares issued with Series D Preferred Shares, shares |
|
|
6,000,000
|
|
|
|
|
|
Commitment shares issued with Series D Preferred Shares, amount |
|
|
$ 600
|
(600)
|
|
|
|
0
|
Common stock issued to consultant - shares |
|
|
1,500,000
|
|
|
|
|
|
Common stock issued to consultant - amount |
|
|
$ 150
|
616,350
|
|
|
|
616,500
|
Common stock to be issued as finder's fees related to asset acquisition |
|
|
|
|
135,775
|
|
|
135,775
|
Net loss |
|
|
|
|
|
(608,764)
|
(1,074)
|
(609,838)
|
Ending balance - shares at Dec. 31, 2020 |
5,000,000
|
1,920
|
544,989,181
|
|
|
|
|
|
Ending balance - amount at Dec. 31, 2020 |
$ 500
|
$ 0
|
$ 54,500
|
$ 55,437,431
|
$ 135,775
|
$ (49,961,843)
|
$ (86,756)
|
$ 5,578,832
|